CLINICAL_TRIALS
trial_result
· 2011-02-01
Clinical Trial Update: Efficacy of DNK333 in Patients With COPD and Cough [Phase 1, Phase 2]
Summary
Phase 1/2 trial of DNK333 in chronic obstructive pulmonary disease with cough has completed and shown efficacy signals.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1, Phase 2 | Status: COMPLETED